Cairo – Mubasher: Glaxo SmithKline said it plans to duplicate the production units of liquid medicines in 2016, through injecting investments worth EGP 60 million ($6.7 million).
The drug firm pointed out that it is close to completing a new production line, in addition to amending the current production line of the liquid medicines during 2016.
The company reported an increase of 7.8% in net profits in 2015 which reached EGP 69.14 million.
